Selective serotonin re-uptake inhibitors and the risk of bleeding

@article{Weinrieb2005SelectiveSR,
  title={Selective serotonin re-uptake inhibitors and the risk of bleeding},
  author={Robert M. Weinrieb and Marc Auriacombe and Kevin G. Lynch and James D. Lewis},
  journal={Expert Opinion on Drug Safety},
  year={2005},
  volume={4},
  pages={337 - 344}
}
Despite their safety, selective serotonin re-uptake inhibitors (SSRIs) are associated with bleeding. The authors critically reviewed the medical literature on SSRIs to identify subgroups of patients at risk of bleeding complications. The authors performed a literature search using MEDLINE from 1966 to 1st September 2004 using; ‘haemorrhage, serotonin uptake inhibitors and antidepressive agents’ as search terms and followed up on citations in each paper that was relevant to SSRI associated… Expand
[SSRI - treatment and bleeding. What risks do we take?].
TLDR
High-risk patients have to be followed up closely and an SSRI with a low potential for drug interaction should be used and the prescription of gastroprotective agents and a change of the antidepressant should be considered in particular cases. Expand
Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.
  • Hai-yin Jiang, Hua-zhong Chen, +5 authors B. Ruan
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2015
TLDR
SSRI use was associated with an almost 2-fold increase in the risk of developing UGIB, especially among patients at high risk for GI bleeding (concurrent use of nonsteroidal anti-inflammatory or antiplatelet drugs). Expand
Selective serotonin reuptake inhibitors and the risk of bleeding
TLDR
Treatment with SSRIs increases the risk of bleeding, however, large, randomized controlled trials are required to re-affirm these findings. Expand
Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
Background: Serotonin plays an important role in the normal clotting phenomenon and is released by platelets. Platelets are dependent on a serotonin transporter for the uptake of serotonin, as theyExpand
Selective serotonin reuptake inhibitors and brain hemorrhage
TLDR
SSRI exposure is associated with an increased risk of intracerebral and intracranial hemorrhage, yet given the rarity of this event, absolute risks are likely to be very low. Expand
Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors
TLDR
Preadmission treatment with SSRIs was not significantly associated with an increased risk of post-thrombolysis sICH in this cohort study, however, subgroup analysis suggested an increase in risk of sich in patients taking both SSRI and OAC. Expand
Treatment of Premature Ejaculation with Selective Serotonin Re-Uptake Inhibitors
TLDR
A meta-analysis has shown that the strongest ejaculation delaying effect of the SSRIs is produced by daily treatment with paroxetine, and that on-demand use of SSRI gives rise to much less ejaculation delay. Expand
A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
TLDR
Although concomitant use of warfarin and PPI appears to be associated with an increased incidence of GIB, these patients are more likely to have other risk factors that also increase the risk of a GIB outcome. Expand
The Safety of Antidepressants
This chapter deals with how the greater molecular selectivity of selective serotonin reuptake inhibitors (SSRIs) in comparison with tricyclics caused a reduced incidence of adverse side effects .Expand
Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment.
TLDR
The frequency of oral bleeding complications after invasive dental treatment is low to negligible in patients on SSRI medications, according to this retrospective cohort study. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.
TLDR
Combining aspirin or nonsteroidal anti-inflammatory drugs with SSRIs for the treatment of interferon-associated neuropsychiatric side effects increases the risks of hemorrhage in patients with HCV who have developed cirrhosis and either portal hypertension or hepatic failure or both. Expand
Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.
TLDR
Selective serotonin reuptake inhibitors increase the risk of upper GI bleeding, and this effect is potentiated by concurrent use of nonsteroidal anti-inflammatory drugs or low-dose aspirin, whereas an increased risk ofupper GI bleeding could not be attributed to other types of antidepressants. Expand
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?
TLDR
Weak evidence is provided to support the hypothesis of a link between SSRIs and precipitation of bleeding events at a population level, and the 95% CI is consistent with a possible risk of bleeding associated with SSRI users versus non-psychiatric drug users in the first month. Expand
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
TLDR
The results are not compatible with a major increased risk of intracranial haemorrhage among users of SSRIs or other antidepressants at large, however, smaller but still relevant increased risks cannot be ruled out. Expand
Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study
TLDR
Current exposure to SSRIs is not associated with increased risk of intracerebral hemorrhage and is probably notassociated with a decreased risk of ischemic stroke. Expand
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study
TLDR
The risk of upper gastrointestinal bleeding in elderly and depressed patients increases with antidepressants having the greatest extent of inhibition of serotonin reuptake, and this increased risk of bleeding is clinically important for patients with a high risk of bleed—namely, octogenarians and those with previous upper gastrointestinal bleed. Expand
Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study
TLDR
The concurrent use of non-steroidal anti-inflammatory drugs or aspirin with selective serotonin reuptake inhibitors greatly increases the risk of upper gastrointestinal bleeding. Expand
Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.
TLDR
It is possible that the effects SSRI on platelet functioning are causing the bleeding observed in some patients and/or that a separate coagulopathy is present and contributing to bleeding. Expand
Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.
TLDR
Peripheral serotonin is important in platelet aggregation and the modulation of vascular tone, and SSRIs block platelet uptake and pulmonary endothelial metabolism of serotonin, and use of these agents may conceivably result in bleeding and vasospastic complications. Expand
Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs
TLDR
NSAIDS should be used cautiously in patients who have other risk factors for UGIB; these include advanced age, smoking, history of peptic ulcer, and use of oral corticosteroids or anticoagulants. Expand
...
1
2
3
4
5
...